1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,021 | 0,035 | 15:08 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 31.08. | Lifecare ASA acquires 80% of Ocean TuniCell securing established GMP manufacturing infrastructure in Bergen | 4 | Oslo Børs | ||
| 31.08. | OCEAN GEOLOOP ASA: Captured AS enters into agreement to sell its shares in its subsidiary Ocean Tunicell AS to Lifecare ASA | 2 | Oslo Børs | ||
| 19.08. | LIFE: Lifecare ASA Q2 2026 results | 4 | Oslo Børs | ||
| 12.08. | Lifecare ASA (LIFE): Invitation to presentation of Q2 2026 results 19 August at 08.45 CEST | 1 | Oslo Børs | ||
| 02.07. | Lifecare ASA: LIFE: Update on production transfer and longevity programme | 2 | Oslo Børs | ||
| 26.06. | Lifecare ASA: LIFE: Operational update regarding Lifecare Germany GmbH (i.L) | 4 | Oslo Børs | ||
| LIFECARE ASA Aktie jetzt für 0€ handeln | |||||
| 22.06. | Lifecare ASA: Share capital increase registered | 6 | Oslo Børs | ||
| 22.06. | Lifecare ASA: LIFE: Independent tissue analysis confirms no adverse tissue response after six months of implantation | 3 | Oslo Børs | ||
| 12.06. | Lifecare ASA: Final results following expiry of exercise period for Warrants Series 2 issued in connection with Rights Issue | 6 | Oslo Børs | ||
| 12.06. | Lifecare ASA: Last day of the Exercise Period for Warrants Series 2 issued in connection with the Rights Issue | 3 | Oslo Børs | ||
| 10.06. | Lifecare ASA: Mandatory notification of trade | 2 | Oslo Børs | ||
| 10.06. | Lifecare ASA: Lifecare completes first six-month implant evaluation with continued functionality and no adverse biological response | 1 | Oslo Børs | ||
| 05.06. | Lifecare ASA: Last day of trading in Warrants Series 2 issued in connection with the Rights Issue | 2 | Oslo Børs | ||
| 03.06. | Lifecare ASA: Mandatory notification of trade | 1 | Oslo Børs | ||
| 01.06. | Lifecare ASA: Commencement of the Exercise Period for Warrants Series 2 issued in connection with the Rights Issue | 2 | Oslo Børs | ||
| 29.05. | Lifecare ASA: Exercise price for Warrants Series 2 issued in connection with the Rights Issue | - | Oslo Børs | ||
| 15.05. | LIFE: Lifecare ASA Q1 2026 results | 3 | Oslo Børs | ||
| 07.05. | Lifecare ASA: Financial calendar | 1 | Oslo Børs | ||
| 07.05. | Lifecare ASA (LIFE): Invitation to Q1 2026 results presentation | 3 | Oslo Børs | ||
| 23.04. | Lifecare ASA: Minutes from Annual General meeting 2026 | 17 | Oslo Børs |
1 2 Weiter >>
29 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,085 | -4,06 % | Stocks in Play: Sernova Biotherapeutics | ||
| BOSTON SCIENTIFIC | 37,500 | +1,02 % | Aktien New York Ausblick: Dow schwächelt weiter - Nasdaq stabil erwartet | NEW YORK (dpa-AFX) - Die US-Börsen steuern nach dem verlängerten Wochenende am Dienstag auf eine durchwachsene Eröffnung zu. Auf die Stimmung drückten die weiter steigenden Ölpreise, die der Angst... ► Artikel lesen | |
| PAUL HARTMANN | 201,00 | +0,50 % | Januar bis Juni 2026: PAUL HARTMANN steigert erneut Umsatz und Ergebnis | Heidenheim (ots) - - Erfolgreiches 1. Halbjahr: Umsatzerlöse steigen auf 1.252,0 Mio. EUR, organisches Umsatzwachstum von 3,3 %; bereinigtes EBITDA liegt mit 151,7 Mio. EUR um 25,9 Mio. EUR über Vorjahreswert-... ► Artikel lesen | |
| SYSMEX | 9,830 | +1,07 % | Sysmex Europe SE and Cytek Biosciences, Inc. Collaborate to Expand Access to Advanced Clinical Flow Cytometry | FREMONT, Calif., and HAMBURG, Germany, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Sysmex Europe SE, a leader in diagnostic and healthcare solutions, and Cytek Biosciences, Inc. (Nasdaq: CTKB), a leader in spectral... ► Artikel lesen | |
| EMBECTA | 4,744 | +12,52 % | Dividendenbekanntmachungen (27.08.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADDTECH AB SE0014781795 3,6 SEK 0,3243 EUR ALLIANCE WITAN PLC GB00B11V7W98 0,0733 GBP 0,0855 EUR ATMUS FILTRATION TECHNOLOGIES... ► Artikel lesen | |
| ADDLIFE | 13,490 | -3,78 % | AddLife AB: AddLife acquires Unicam Sistemas Analíticos Lda | AddLife has acquired Unicam Sistemas Analíticos, a leading Portuguese distributor of advanced analytical laboratory equipment. The company will be included within AddLife's Business Area Labtech.Unicam... ► Artikel lesen | |
| ENOVIS | 16,200 | +1,89 % | Enovis auf Wells-Fargo-Konferenz: Robotik-Strategie rückt in den Mittelpunkt | ||
| PULMONX | 1,600 | 0,00 % | Pulmonx Corporation: Pulmonx Reports Second Quarter 2026 Financial Results | REDWOOD CITY, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported... ► Artikel lesen | |
| SI-BONE | 15,400 | 0,00 % | SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance | Delivered ~15% WW revenue growth and ~178% increase in adjusted EBITDA ~19% increase in U.S. physician base Second Quarter 2026 Financial Highlights (all comparisons are to the prior year period)... ► Artikel lesen | |
| KOOTH | 2,040 | 0,00 % | Kooth PLC - Notice of Half Year Results | ||
| PEIJIA MEDICAL | 0,488 | -1,61 % | Peijia Medical Announces 2026 Interim Results, Achieving First-Ever Profit Before Tax on Strong TAVR Growth | SUZHOU, China, Aug. 24, 2026 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and... ► Artikel lesen | |
| BACTIGUARD | 1,285 | 0,00 % | Bactiguard Holding AB: Bactiguard Holding AB's interim report second quarter 2026 | Solid performance driven by revenue growth
Second quarter 2026 (April - June)Total revenue amounted to SEK 57.1 (52.1) million, an increase of SEK 4.9 million corresponding to 9%.Net sales amounted... ► Artikel lesen | |
| SCIBASE | 1,505 | 0,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 08.09.2026 | Das Instrument 7M8 SE0003273531 ECORUB AB B EQUITY wird cum Kapitalmassnahme gehandelt am 08.09.2026 und ex Kapitalmassnahme am 09.09.2026 The instrument 7M8 SE0003273531 ECORUB AB B EQUITY is traded... ► Artikel lesen | |
| PHC HOLDINGS | 6,650 | -1,48 % | PHC Holdings Corporation: Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership | A pioneering pathology technology developed by Leeds Teaching Hospitals NHS Trust is set for international deployment after securing a commercial agreement with Epredia, a global leader in precision... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 57,88 | 0,00 % | BrightSpring auf Wells Fargo Konferenz: Wachstum beschleunigt sich auf breiter Front |
Das Unternehmen LIFECARE ASA kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,011 Euro und damit -57,85 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LIFECARE ASA finden Sie auf Wallstreet Online.